Cyclerion Therapeutics Inc. (NASDAQ: CYCN) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT CYCLERION THERAPEUTICS INC.

Cyclerion Therapeutics Inc. (NASDAQ: CYCN)
Listen to this Section


$4.20
+0.0100 ( +2.94% ) 7.5K

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Market Data


Open $4.20
Previous Close $4.19
Volume 7.5K
Market Cap $11.36M
Day Range $4.05 - $4.27
52 Week Range $1.27 - $9.47
Shares Outstanding 2.71M
Change % +2.94%
Net Change ▲ 0.0100
Insider Ownership -0.04%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Pharmaceutical Preparations
IPO Year 2019
Country United States

Insider Ownership Transactions

Total Amount Purchased: -185,857.00

Date Type Amount Purchased Purchaser
2024-08-07 Sale -55849.00 Graul Regina Margaret
2024-01-26 Sale -50000.00 Graul Regina Margaret
2024-01-26 Sale -15000.00 Hecht Peter M
2023-12-04 Sale -20000.00 Hyman Steven
2023-12-04 Sale -20000.00 DESOUZA ERROL B
2023-12-04 Sale -20000.00 Hecht Peter M
2023-12-04 Sale -5000.00 MCGUIRE TERRANCE
2023-08-11 Sale -8.00 MCGUIRE TERRANCE

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 16 Dec 17, 2024
schedule Other 1 Dec 06, 2024
4 Insider transactions 1 Nov 25, 2024
10-q Quarterly Reports 63 Nov 14, 2024
8-k 8K-related 15 Aug 07, 2024
10-q Quarterly Reports 63 Aug 07, 2024
4 Insider transactions 1 Aug 07, 2024
sc Insider transactions 1 Jul 12, 2024
8-k 8K-related 13 Jun 14, 2024
10-q Quarterly Reports 62 May 07, 2024

Latest News


× Before browsing our site, please accept our cookies policy